{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T04:19:40Z","timestamp":1744777180608,"version":"3.40.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004721","name":"The University of Tokyo","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004721","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Digital ulcers in patients with systemic sclerosis (SSc) can be complicated by SSc-related osteomyelitis (SRO). The microbiological data and optimal management of SRO remain unclear. This single-center retrospective study involved patients with SSc aged 18 or older from April 2005 to March 2022. Diagnosis of SRO was based on clinical presentation and MRI findings. The accuracy of the superficial swab culture results was estimated using the bone culture as a reference. Temporal changes in local signs for up to a year were collected, and their association with (1) duration of antimicrobial therapy (&gt;\u20096 weeks) or (2) surgical interventions was assessed using univariable analyses. Among the 2,126 patients, 46 (2.2%) were diagnosed with SRO. In seven patients whose swab and bone cultures were both available, two (28.6%) had swab cultures identifying all the organisms detected in bone cultures. Resolution of local inflammatory signs consistently preceded wound closure. Three months after therapy initiation, prolonged antimicrobial therapy was not significantly associated with the resolution of local inflammatory signs (16\/19 [84.2%] vs. 12\/14 [85.7%]; <jats:italic>P<\/jats:italic>\u2009=\u20091.00), and surgical intervention was not significantly associated with wound dehiscence (6\/9 [66.7%] vs. 20\/24 [83.3%]; <jats:italic>P<\/jats:italic>\u2009=\u20090.36). Superficial swab cultures may not reliably reflect the true causative organism of SRO. Prolonging antimicrobial therapy beyond six weeks may be of little benefit for patients with SRO when local inflammatory signs improve. Surgical intervention may be a safe and effective option for selected patients with SRO.<\/jats:p>","DOI":"10.1007\/s00296-025-05815-5","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T07:56:55Z","timestamp":1741766215000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Characteristics and management of systemic sclerosis-related osteomyelitis: a retrospective cohort study"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1630-1313","authenticated-orcid":false,"given":"Toshiki","family":"Miwa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4072-9096","authenticated-orcid":false,"given":"Koh","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0531-559X","authenticated-orcid":false,"given":"Hayakazu","family":"Sumida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2484-3187","authenticated-orcid":false,"given":"Satoshi","family":"Toyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5519-172X","authenticated-orcid":false,"given":"Shinichi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0851-1887","authenticated-orcid":false,"given":"Takeya","family":"Tsutsumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,12]]},"reference":[{"issue":"10373","key":"5815_CR1","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/s0140-6736(22)01692-0","volume":"401","author":"ER Volkmann","year":"2023","unstructured":"Volkmann ER, Andr\u00e9asson K, Smith V (2023) Systemic sclerosis. Lancet 401(10373):304\u2013318. https:\/\/doi.org\/10.1016\/s0140-6736(22)01692-0","journal-title":"Lancet"},{"issue":"3","key":"5815_CR2","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.rdc.2015.04.005","volume":"41","author":"L Cappelli","year":"2015","unstructured":"Cappelli L, Wigley FM (2015) Management of Raynaud Phenomenon and Digital Ulcers in Scleroderma. Rheum Dis Clin North Am 41(3):419\u2013438. https:\/\/doi.org\/10.1016\/j.rdc.2015.04.005","journal-title":"Rheum Dis Clin North Am"},{"issue":"9","key":"5815_CR3","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.3899\/jrheum.121380","volume":"40","author":"C Muangchan","year":"2013","unstructured":"Muangchan C, Baron M, Pope J (2013) The 15% rule in scleroderma: the frequency of severe organ complications in systemic sclerosis. A systematic review. J Rheumatol 40(9):1545\u20131556. https:\/\/doi.org\/10.3899\/jrheum.121380","journal-title":"J Rheumatol"},{"key":"5815_CR4","doi-asserted-by":"publisher","unstructured":"Steen V, Denton CP, Pope JE, Matucci-Cerinic M (2009) Digital ulcers: overt vascular disease in systemic sclerosis. Rheumatology (Oxford) 48 Suppl 3:iii19-24. https:\/\/doi.org\/10.1093\/rheumatology\/kep105","DOI":"10.1093\/rheumatology\/kep105"},{"issue":"2","key":"5815_CR5","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.autrev.2017.11.020","volume":"17","author":"D Giuggioli","year":"2018","unstructured":"Giuggioli D, Manfredi A, Lumetti F, Colaci M, Ferri C (2018) Scleroderma skin ulcers definition, classification and treatment strategies our experience and review of the literature. Autoimmun Rev 17(2):155\u2013164. https:\/\/doi.org\/10.1016\/j.autrev.2017.11.020","journal-title":"Autoimmun Rev"},{"issue":"6","key":"5815_CR6","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.55730\/1300-0144.5535","volume":"52","author":"ME Yayla","year":"2022","unstructured":"Yayla ME, Yurteri EU, Torgutalp M, Ero\u011flu D, Sezer S, Din\u00e7er ABK, G\u00fcl\u00f6ks\u00fcz EGA, Y\u00fcksel ML, Y\u0131lmaz R, Ate\u015f A, Turgay TM, K\u0131n\u0131kl\u0131 G (2022) Causes of severe infections in patients with systemic sclerosis and associated factors. Turk J Med Sci 52(6):1881\u20131888. https:\/\/doi.org\/10.55730\/1300-0144.5535","journal-title":"Turk J Med Sci"},{"issue":"5","key":"5815_CR7","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s10067-012-2161-7","volume":"32","author":"D Giuggioli","year":"2013","unstructured":"Giuggioli D, Manfredi A, Colaci M, Lumetti F, Ferri C (2013) Osteomyelitis complicating scleroderma digital ulcers. Clin Rheumatol 32(5):623\u2013627. https:\/\/doi.org\/10.1007\/s10067-012-2161-7","journal-title":"Clin Rheumatol"},{"issue":"9","key":"5815_CR8","doi-asserted-by":"publisher","first-page":"ofac407","DOI":"10.1093\/ofid\/ofac407","volume":"9","author":"DH Truong","year":"2022","unstructured":"Truong DH, Bedimo R, Malone M, Wukich DK, Oz OK, Killeen AL, Lavery LA (2022) Meta-analysis: outcomes of Surgical and Medical Management of Diabetic Foot Osteomyelitis. Open Forum Infect Dis 9(9):ofac407. https:\/\/doi.org\/10.1093\/ofid\/ofac407","journal-title":"Open Forum Infect Dis"},{"issue":"9971","key":"5815_CR9","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/s0140-6736(14)61233-2","volume":"385","author":"L Bernard","year":"2015","unstructured":"Bernard L, Dinh A, Ghout I, Simo D, Zeller V, Issartel B, Le Moing V, Belmatoug N, Lesprit P, Bru JP, Therby A, Bouhour D, D\u00e9nes E, Debard A, Chirouze C, F\u00e8vre K, Dupon M, Aegerter P, Mulleman D (2015) Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial. Lancet 385(9971):875\u2013882. https:\/\/doi.org\/10.1016\/s0140-6736(14)61233-2","journal-title":"Lancet"},{"issue":"1","key":"5815_CR10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1086\/498112","volume":"42","author":"E Senneville","year":"2006","unstructured":"Senneville E, Melliez H, Beltrand E, Legout L, Valette M, Cazaubiel M, Cordonnier M, Caillaux M, Yazdanpanah Y, Mouton Y (2006) Culture of percutaneous bone biopsy specimens for diagnosis of diabetic foot osteomyelitis: concordance with ulcer swab cultures. Clin Infect Dis 42(1):57\u201362. https:\/\/doi.org\/10.1086\/498112","journal-title":"Clin Infect Dis"},{"issue":"6 Suppl 86","key":"5815_CR11","first-page":"S","volume":"32","author":"AY Zhou","year":"2014","unstructured":"Zhou AY, Muir L, Harris J, Herrick AL (2014) The impact of magnetic resonance imaging in early diagnosis of hand osteomyelitis in patients with systemic sclerosis. Clin Exp Rheumatol 32(6 Suppl 86):S\u2013232","journal-title":"Clin Exp Rheumatol"},{"issue":"8s","key":"5815_CR12","doi-asserted-by":"publisher","first-page":"S342","DOI":"10.1097\/rhu.0000000000001621","volume":"27","author":"A Haque","year":"2021","unstructured":"Haque A, Wyman M, Dargan D, Hughes M, Musson R, Caddick J, Giblin V (2021) Hand Osteomyelitis in patients with secondary Raynaud Phenomenon. J Clin Rheumatol 27(8s):S342\u2013s345. https:\/\/doi.org\/10.1097\/rhu.0000000000001621","journal-title":"J Clin Rheumatol"},{"key":"5815_CR13","unstructured":"The University of Tokyo Hospital Scleroderma Center\u2009<\u2009https:\/\/dermatology.m.u-tokyo.ac.jp\/top\/about-dermatology\/speciality\/ssc\/ [Accessed 14 July 2024]"},{"issue":"11","key":"5815_CR14","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","volume":"72","author":"F van den Hoogen","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, Medsger TA Jr., Carreira PE, Riemekasten G, Clements PJ, Denton CP, Distler O, Allanore Y, Furst DE, Gabrielli A, Mayes MD, van Laar JM, Seibold JR, Czirjak L, Steen VD, Inanc M, Kowal-Bielecka O, M\u00fcller-Ladner U, Valentini G, Veale DJ, Vonk MC, Walker UA, Chung L, Collier DH, Ellen Csuka M, Fessler BJ, Guiducci S, Herrick A, Hsu VM, Jimenez S, Kahaleh B, Merkel PA, Sierakowski S, Silver RM, Simms RW, Varga J, Pope JE (2013) 2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative. Ann Rheum Dis 72(11):1747\u20131755. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204424","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"5815_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5301\/jsrd.5000231","volume":"2","author":"D Khanna","year":"2017","unstructured":"Khanna D, Furst DE, Clements PJ, Allanore Y, Baron M, Czirjak L, Distler O, Foeldvari I, Kuwana M, Matucci-Cerinic M, Mayes M, Medsger T Jr., Merkel PA, Pope JE, Seibold JR, Steen V, Stevens W, Denton CP (2017) Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis. J Scleroderma Relat Disord 2(1):11\u201318. https:\/\/doi.org\/10.5301\/jsrd.5000231","journal-title":"J Scleroderma Relat Disord"},{"issue":"2","key":"5815_CR16","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/acr.20673","volume":"64","author":"D Giuggioli","year":"2012","unstructured":"Giuggioli D, Manfredi A, Colaci M, Lumetti F, Ferri C (2012) Scleroderma digital ulcers complicated by infection with fecal pathogens. Arthritis Care Res (Hoboken) 64(2):295\u2013297. https:\/\/doi.org\/10.1002\/acr.20673","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"7","key":"5815_CR17","doi-asserted-by":"publisher","first-page":"ofac297","DOI":"10.1093\/ofid\/ofac297","volume":"9","author":"MP Veve","year":"2022","unstructured":"Veve MP, Mercuro NJ, Sangiovanni RJ, Santarossa M, Patel N (2022) Prevalence and predictors of Pseudomonas aeruginosa among hospitalized patients with Diabetic Foot infections. Open Forum Infect Dis 9(7):ofac297. https:\/\/doi.org\/10.1093\/ofid\/ofac297","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"5815_CR18","doi-asserted-by":"publisher","first-page":"302","DOI":"10.2337\/dc14-1514","volume":"38","author":"A Tone","year":"2015","unstructured":"Tone A, Nguyen S, Devemy F, Topolinski H, Valette M, Cazaubiel M, Fayard A, Beltrand \u00c9, Lemaire C, Senneville \u00c9 (2015) Six-week versus twelve-week antibiotic therapy for nonsurgically treated diabetic foot osteomyelitis: a multicenter open-label controlled randomized study. Diabetes Care 38(2):302\u2013307. https:\/\/doi.org\/10.2337\/dc14-1514","journal-title":"Diabetes Care"},{"key":"5815_CR19","doi-asserted-by":"publisher","unstructured":"Iranparvar M, Arzanlou M, Afrouzeh E (2019) Comparison of the efficacy of six-week versus twelve-week antibiotic therapy for the treatment of nonsurgical diabetic foot osteomyelitis. Int Med 1(5). https:\/\/doi.org\/10.5455\/im.53372","DOI":"10.5455\/im.53372"},{"issue":"3","key":"5815_CR20","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciad255","volume":"77","author":"NW Cortes-Penfield","year":"2023","unstructured":"Cortes-Penfield NW, Armstrong DG, Brennan MB, Fayfman M, Ryder JH, Tan TW, Schechter MC (2023) Evaluation and management of diabetes-related foot infections. Clin Infect Dis 77(3):e1\u2013e13. https:\/\/doi.org\/10.1093\/cid\/ciad255","journal-title":"Clin Infect Dis"},{"issue":"6","key":"5815_CR21","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.jhsa.2018.03.021","volume":"43","author":"AA Williams","year":"2018","unstructured":"Williams AA, Carl HM, Lifchez SD (2018) The Scleroderma Hand: manifestations of Disease and Approach to Management. J Hand Surg Am 43(6):550\u2013557. https:\/\/doi.org\/10.1016\/j.jhsa.2018.03.021","journal-title":"J Hand Surg Am"},{"issue":"4","key":"5815_CR22","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41584-023-00909-5","volume":"19","author":"JE Pope","year":"2023","unstructured":"Pope JE, Denton CP, Johnson SR, Fernandez-Codina A, Hudson M, Nevskaya T (2023) State-of-the-art evidence in the treatment of systemic sclerosis. Nat Rev Rheumatol 19(4):212\u2013226. https:\/\/doi.org\/10.1038\/s41584-023-00909-5","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"5815_CR23","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.berh.2018.08.005","volume":"32","author":"F Ingegnoli","year":"2018","unstructured":"Ingegnoli F, Ughi N, Mihai C (2018) Update on the epidemiology, risk factors, and disease outcomes of systemic sclerosis. Best Pract Res Clin Rheumatol 32(2):223\u2013240. https:\/\/doi.org\/10.1016\/j.berh.2018.08.005","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"1","key":"5815_CR24","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1136\/ard.2010.130658","volume":"70","author":"M Matucci-Cerinic","year":"2011","unstructured":"Matucci-Cerinic M, Denton CP, Furst DE, Mayes MD, Hsu VM, Carpentier P, Wigley FM, Black CM, Fessler BJ, Merkel PA, Pope JE, Sweiss NJ, Doyle MK, Hellmich B, Medsger TA Jr., Morganti A, Kramer F, Korn JH, Seibold JR (2011) Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial. Ann Rheum Dis 70(1):32\u201338. https:\/\/doi.org\/10.1136\/ard.2010.130658","journal-title":"Ann Rheum Dis"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-025-05815-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-025-05815-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-025-05815-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T09:39:40Z","timestamp":1744709980000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-025-05815-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,12]]},"references-count":24,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["5815"],"URL":"https:\/\/doi.org\/10.1007\/s00296-025-05815-5","relation":{},"ISSN":["1437-160X"],"issn-type":[{"type":"electronic","value":"1437-160X"}],"subject":[],"published":{"date-parts":[[2025,3,12]]},"assertion":[{"value":"27 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"KO received lectures and medical advice honoraria from Thermo Fisher Scientific; Becton, Dickinson and Company; Eiken Chemical Co.; and Kyorin Pharmaceutical Co.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"73"}}